COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance

The COVID-19 pandemic saw unprecedented resources and funds driven into research for the development, and subsequent rapid distribution, of vaccines, diagnostics and directly acting antivirals (DAAs). DAAs have undeniably prevented progression and life-threatening conditions in patients with severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bou-Antoun, Sabine, Rokadiya, Sakib, Ashiru-Oredope, Diane, Demirjian, Alicia, Sherwood, Emma, Ellaby, Nicholas, Gerver, Sarah, Grossi, Carlota, Harman, Katie, Hartman, Hassan, Lochen, Alessandra, Ragonnet-Cronin, Manon, Squire, Hanna, Sutton, J Mark, Thelwall, Simon, Tree, Julia, Bahar, Mohammad W, Stuart, David I, Brown, Colin S, Chand, Meera, Hopkins, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Supplement Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666993/
https://www.ncbi.nlm.nih.gov/pubmed/37995354
http://dx.doi.org/10.1093/jac/dkad314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666993/
https://www.ncbi.nlm.nih.gov/pubmed/37995354
http://dx.doi.org/10.1093/jac/dkad314

Ejemplares similares